Pulmonary emboli management trial
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial is for anyone with a pulmonary embolism (a blood clot in the lung). It tests different ways to manage the clot and aims to find the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pulmonary embolism (a blood clot in your lung).
- You are able to receive treatment for it.
- You are willing to participate in a study that compares management approaches.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This trial compares three treatments for an intermediate-high risk pulmonary embolism: a minimally invasive clot removal procedure (embolectomy), a low-dose clot-dissolving medication, or standard blood thinning (heparin). The goal is to see which approach works best to prevent worsening while reducing bleeding risks.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
This trial looks at how long people need blood-thinning medicine after a serious blood clot in the lungs. It might help doctors find the best treatment length for each person.
Hear when a new Pulmonary Embolism (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.